The role of hematopoietic stem cell transplantation for acute myeloid leukemia

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Hematopoietic stem cell transplantation (HSCT) plays an important role in treating younger patients with acute myeloid leukemia (AML). Reduced-intensity conditioning regimens allow increased use of allogeneic HSCT for older patients. Current HSCT decisions in patients with AML are being made according to cytogenetic analysis results. A more comprehensive and detailed understanding of the genetic and epigenetic changes that are related to the pathogenesis of AML is required for better classification of risk and for improving approaches to therapy as they pertain to future HSCT decisions.

    Original languageEnglish
    Pages (from-to)1950-1959
    Number of pages10
    Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
    Volume56
    Issue number10
    DOIs
    Publication statusPublished - Oct 1 2015

    All Science Journal Classification (ASJC) codes

    • Medicine(all)

    Fingerprint Dive into the research topics of 'The role of hematopoietic stem cell transplantation for acute myeloid leukemia'. Together they form a unique fingerprint.

    Cite this